Jul 3
A novel mouse model of sickle cell SC disease; multiple myeloma induction therapy with isatuximab, carfilzomib, lenalidomide, and dexamethasone; and splicing factor mutations in myelodysplastic syndromes
In this week's episode we’ll learn more about a novel mouse model that recapitulates many of the properties of human sickle cell SC disease; results from the induction phase of the risk-adapted MIDAS trial of isatuximab, carfilzomib, lenalidomide, and dexamethasone in newly diagn ... Show More
19m 8s
Jun 26
An AI model for transplant risk in myelofibrosis; preventing priapism in men with sickle cell anemia; hallmarks of T cell exhaustion absent in newly diagnosed MM
In this week's episode, we'll learn about using AI to assess transplant risk in myelofibrosis. In a step toward personalized medicine, researchers report on a machine learning model that identifies 25% of patients with poor outcomes. After that: preventing priapism in men with si ... Show More
18m 24s
Jun 23
Social determinants of health and access to allogeneic hematopoietic cell transplantation, megakaryocyte growth factor receptor-based pretransplant conditioning for ex vivo autologous gene therapy, and novel protein biomarkers for risk stratification in a
In this week's episode, we’ll learn more about social determinants of health that impact access to allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia, or AML; use of megakaryocyte growth factor receptor-based stem cell depletion as part of pretr ... Show More
19m 38s
Feb 2025
Ophthalmology Reviews: A New Frontier in the Ophthalmology Family of Journals
Ophthalmology Editor-in-Chief, Russell Van Gelder, MD, PhD, and our new Associate Editor, Laura Downie, BOptom, PhD, guest host this special episode introducing “Ophthalmology Reviews.” Ophthalmology Reviews is a new section in our flagship journal for structured systematic revie ... Show More
14m 50s
Dec 2023
Dec 01 2023 This Week in Cardiology
More from AHA including SGLT2 inhibitors, blood transfusion after MI; cracks in the armor of Factor XI inhibitors; and renal denervation are the topics John Mandrola, MD, covers in this week’s podcast. This podcast is intended for healthcare professionals only. To read a partial ... Show More
27m 48s
May 2024
Episode 104: Colorectal Cancer Series, Pt. 6 - Colorectal Cancer Pharmacology
We have another guest joining us this week! Dr. Allison Schepers, PharmD, BCOP is a Clinical Pharmacist Specialist at the Rogel Cancer Center at the University of Michigan where she focuses on GI, GU, and Thoracic malignancies! In this episode, Allison discusses the high yield po ... Show More
38m 36s
Jun 2024
Episode 105: Colorectal Cancer Series, Pt. 7 - Management of Rectal Cancer
This week, we incorporate medical oncology back into our discussion with our Radiation Oncologist, Dr. Sanford, and our Surgical Oncologist, Dr. Bailey. We discuss how we approach the management of localized rectal cancer. Note that we will be heavily building off our discussions ... Show More
32m 55s
Nov 2023
Blood, Bleeding, and Transfusion Theme Issue
Editor’s Summary by Christopher W. Seymour, MD, MSc, Associate Editor of JAMA, the Journal of the American Medical Association, for the November 21, 2023, issue. Related Content: Audio Highlights
9m 25s
Oct 2024
254. Months of Monocytosis – An approach to CMML
Send us a textIn this episode, we discuss the clinical presentation, work-up, and treatment of CMML. Our medicine minute discusses emerging evidence on the use of ruxolitinib for CMML treatment.
Written by: Dr. Elliot Smith (Internal Medicine Resident)
Reviewed by: Dr. Stephanie ... Show More
17m 17s
Feb 2025
Type 2 Diabetes Treatments and Major Adverse Cardiovascular Events by Age and Sex, Simvastatin with Rifaximin for Decompensated Liver Cirrhosis, Approved vs Off-label Doxepin Formulation Trends and mo
Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from February 1-7, 2025.
9m 51s